Nutrien (NTR) Stock Forecast & Price Target
$32.67B
Market Cap
13.99
P/E
13.96
Forward P/E
55
Score
NTR price $68.45 -0.61 -0.89%
Stocklytics score rationale: value 54, quality 54, growth 56.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 4456000000 | 4547000000 | 19636000000 | 20084000000 | 20908000000 | 27712000000 | 37884000000 | 29056000000 | 25972000000 | 26885000000 |
Nutrien Ltd., a company established in 2017 and based in Saskatoon, Canada, functions as a principal supplier of essential agricultural resources and associated services. The firm furnishes vital crop inputs, including various fertilizer compounds like potash, nitrogen, phosphate, and sulfate, in addition to offering financial solutions to its clientele. Its operations involve the extensive distribution of…
Consensus Buy from 33 analysts. Average price target $77.29, +12.9% versus the current price. Low $65.00. High $90.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $77.29 for Nutrien (NTR), 12.9% above the current price of $68.45. Of 33 analysts covering the stock, 20 rate it Buy or Strong Buy, 10 Hold, and 3 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $65.00 |
|---|---|
| Average | $77.29 |
| High | $90.00 |
The average is 12.9% above the current price of $68.45.
Of 33 analysts, 20 rate Nutrien Buy or Strong Buy, 10 Hold, and 3 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $4.90, revenue $27.64 billion. 2027, EPS $5.09, revenue $27.57 billion.
The Stocklytics Score for NTR is 55 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$77.29 average, with a published range of $65.00 to $90.00.
The consensus is Buy from 33 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $4.90. The average revenue estimate is $27.64 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Nutrien · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$32.67B
Market Cap
13.99
P/E
13.96
Forward P/E
55
Score